Civic Intelligence

Global Coalition for Adaptive Research Inc.

990EZ • Fiscal year 2017 • EIN 82-1199380

Jan 01, 2017 to Dec 31, 2017 • Filed on May 15, 2018

1661 Massachusetts Avenue Box 427Lexington, MA 02420-9998

(617) 299-6471

Siviq Scores

Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.

Liabilities / Assets

99th percentile

6.80x

Higher debt load relative to assets than 99% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

Score unavailable

No value available

Liabilities-to-revenue requires both liabilities and revenue on this filing.

Source year 2017

Net Margin

Score unavailable

No value available

Net margin requires both revenue and expenses on this filing.

Source year 2017

Top Officer Pay

76th percentile

$0

Higher top officer pay than 76% of similar nonprofits.

2017 filings • 501(c)3 • <$500k nonprofits • Source year 2017

Asset Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Revenue Growth

Score unavailable

No value available

No earlier valid filing was available within the previous three public years.

Source year 2017

Assets

$44,119

No earlier filing loaded for comparison.

Net Assets

-$105,881

No earlier filing loaded for comparison.

Liabilities

$300,000

No earlier filing loaded for comparison.

Revenue

$0

No earlier filing loaded for comparison.

Expenses

$105,881

No earlier filing loaded for comparison.

Net Income

-$105,881

No earlier filing loaded for comparison.

Historical Trend

Balance Sheet Trend

The highlighted filing sits inside the broader history for assets, liabilities, and net assets.

$80M$60M$40M$20M$0-$20MAssets 2017: $44,119Liabilities 2017: $300,000Net Assets 2017: -$105,8812017Assets 2018: $109,128Liabilities 2018: $157,655Net Assets 2018: -$48,5272018Assets 2019: $7,395,124Liabilities 2019: $755,402Net Assets 2019: $6,639,7222019Assets 2020: $28,309,589Liabilities 2020: $23,032,332Net Assets 2020: $5,277,2572020Assets 2021: $40,740,875Liabilities 2021: $13,880,420Net Assets 2021: $26,860,4552021Assets 2022: $59,575,227Liabilities 2022: $21,752,254Net Assets 2022: $37,822,9732022Assets 2023: $59,610,730Liabilities 2023: $19,617,460Net Assets 2023: $39,993,2702023Assets 2024: $63,602,270Liabilities 2024: $24,355,112Net Assets 2024: $39,247,1582024

Highlighted filing

2017

Assets$44,119
Liabilities$300,000
Net Assets-$105,881

Operations Trend

Revenue, expenses, and net income across loaded years, with this filing highlighted.

$40M$20M$0-$20MRevenue 2017: $0Expenses 2017: $105,881Net Income 2017: -$105,8812017Revenue 2018: $2,525,750Expenses 2018: $2,468,396Net Income 2018: $57,3542018Revenue 2019: $11,915,160Expenses 2019: $5,226,911Net Income 2019: $6,688,2492019Revenue 2020: $15,863,066Expenses 2020: $10,452,245Net Income 2020: $5,410,8212020Revenue 2021: $38,719,697Expenses 2021: $19,203,165Net Income 2021: $19,516,5322021Revenue 2022: $35,373,148Expenses 2022: $24,083,323Net Income 2022: $11,289,8252022Revenue 2023: $28,779,160Expenses 2023: $29,710,627Net Income 2023: -$931,4672023Revenue 2024: $27,688,488Expenses 2024: $30,895,157Net Income 2024: -$3,206,6692024

Highlighted filing

2017

Revenue$0
Expenses$105,881
Net Income-$105,881
Jump To
Filing Snapshot
Filing Period
Jan 1, 2017 to Dec 31, 2017
Signed
May 15, 2018
Return Version
2017v2.3
Mission and Program Overview

Mission

Our mission is to lead the development and ongoing management of clinical trial platforms to accelerate the discovery and development of cures for patients with rare and deadly diseases.

1)to provide grants, funds, aid and assistance to scientific and medical institutes, scientists and physicians engaged in medical and scientific research as to the causes of, prevention of, iearly diagnosis of, and treatment of cancers of all types; 2)to promote and support the use of cancer-specific platform trials of new drugs and other treatments of cancer so that multiple treatment modalities may be tested and evaluated simultaneously; ongoing clinical trials may be continuously updated to incorporate the latest clinical trial research results; and the most effective treatment protocols for various types of cancer may be developed and approved sooner; 3)to promote and support financially and otherwise, public education as to the use of cancer-specific platform trials that result in protocols that may lead to earlier diagnosis and treatment of cancers of all types; 4)to underwrite, sponsor, and support academic and scholarly studies, symposia, curricula development, research, semina

Program Services

DescriptionGrantsExpenses
N/A--
Compensation and Service Providers

Employees

NameTitleFull / Part TimeBaseOtherTotal
BRIAN M ALEXANDERPresident-$0--
SUJUAN BASecretary-$0--
WEBSTER CAVENCEOfficer-$0--
TIMOTHY F CLOUGHESYOfficer-$0--
Filing and Contact Details

Filer

Filer Name
Global Coalition for Adaptive
EIN
82-1199380
Phone
6172996471
Address
1661 MASSACHUSETTS AVENUE BOX 427, LEXINGTON, MA 02420-9998

Signing Officer

Name
Brian M Alexander
Title
President
Phone
6172996471
Signed
2018-05-15

Preparer

Firm
Barlow Douglas & Hall Cpas Pllc
Address
1671 W HORIZON RIDGE PKWY STE 220, HENDERSON, NV 89012-3523
Preparer
Dean L Walker CPA
Phone
7022022255
Supplemental Narrative

Additional Explanations

Form 990-ez, Part I, Line 16

Expenses advertising and promotion 15,453 office 3,393 travel 4,989 insurance 3,477 total 27,312

Form 990-ez, Part II, Line 26

Unsecured notes and loans payable 0 150,000 loans from officers 0 150,000

Form 990-ez, Part III

1)to provide grants, funds, aid and assistance to scientific and medical institutes, scientists and physicians engaged in medical and scientific research as to the causes of, prevention of, iearly diagnosis of, and treatment of cancers of all types; 2)to promote and support the use of cancer-specific platform trials of new drugs and other treatments of cancer so that multiple treatment modalities may be tested and evaluated simultaneously; ongoing clinical trials may be continuously updated to incorporate the latest clinical trial research results; and the most effective treatment protocols for various types of cancer may be developed and approved sooner; 3)to promote and support financially and otherwise, public education as to the use of cancer-specific platform trials that result in protocols that may lead to earlier diagnosis and treatment of cancers of all types; 4)to underwrite, sponsor, and support academic and scholarly studies, symposia, curricula development, research, seminars, and presentations as to the topics set forth above in governmental institutions, in the media and in schools, colleges, universities and other educational institutions throughout the united states and abroad; 5)to encourage state and federal government agencies to provide adequate funding to promote the use of cancer-specific platform trials that can lead to more efficacious treatments of cancer and the ability of cancer patients to avail themselves of such treatments sooner than previously possible via standard clinical trial protocols. 6)to accomplish the above purposes by all reasonable and practical means, including the publication and dissemination of information in all forms and through all media, to the public in the united states and in foreign states; and 7)to engage in any lawful acts and enter into all lawful agreements that may be necessary, useful, suitable or proper to accomplish the charitable purposes of the corporation, provided the same is permitted under section 501(c)(3) of the code.

Form 990-ez, Part V, Line 34

The organization amended its articles of incorporation to change its name. A copy of the articles of amenndment was previously submitted to the irs on december 22, 2017.

Raw XML Appendix132 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990EZ/ActivitiesNotPreviouslyRptInd0false
IRS990EZ/BooksInCareOfDetail/PersonNm0BRIAN M ALEXANDER
IRS990EZ/BooksInCareOfDetail/PhoneNum06172996471
IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt0128 KENDALL ROAD
IRS990EZ/BooksInCareOfDetail/USAddress/CityNm0LEXINGTON
IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd0MA
IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd002421
IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt044119
IRS990EZ/ChgMadeToOrgnzngDocNotRptInd0true
IRS990EZ/DonorAdvisedFndsInd0false
IRS990EZ/EngagedInExcessBenefitTransInd0false
IRS990EZ/ExcessOrDeficitForYearAmt0-105881
IRS990EZ/FeesAndOtherPymtToIndCntrctAmt078569
IRS990EZ/FiledScheduleAInd0true
IRS990EZ/ForeignFinancialAccountInd0false
IRS990EZ/ForeignOfficeInd0false
IRS990EZ/Form1120PolFiledInd0false
IRS990EZ/Form990TotalAssetsGrp/BOYAmt00
IRS990EZ/Form990TotalAssetsGrp/EOYAmt044119
IRS990EZ/InfoInScheduleOPartIIIInd0X
IRS990EZ/InfoInScheduleOPartIIInd0X
IRS990EZ/InfoInScheduleOPartIInd0X
IRS990EZ/InfoInScheduleOPartVInd0X
IRS990EZ/InitialReturnInd0X
IRS990EZ/LoansToFromOfficersAmt0150000
IRS990EZ/LobbyingActivitiesInd0false
IRS990EZ/MadeLoansToFromOfficersInd0true
IRS990EZ/MethodOfAccountingCashInd0X
IRS990EZ/NetAssetsOrFundBalancesEOYAmt0-105881
IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt00
IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt0-255881
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt0000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt1000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt2000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt3000.00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt00
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt10
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt20
IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt30
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm0BRIAN M ALEXANDER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm1SUJUAN BA
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm2WEBSTER CAVENCE
IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm3TIMOTHY F CLOUGHESY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt0PRESIDENT
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt1SECRETARY
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt2OFFICER
IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt3OFFICER
IRS990EZ/OperateHospitalInd0false
IRS990EZ/Organization501c3Ind0X
IRS990EZ/OrganizationDissolvedEtcInd0false
IRS990EZ/OrganizationHadUBIInd0false
IRS990EZ/OtherExpensesTotalAmt027312
IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt0NONE
IRS990EZ/PartVIOfCompOfHghstPdEmplTxt0NONE
IRS990EZ/PoliticalCampaignActyInd0false
IRS990EZ/PrimaryExemptPurposeTxt01)TO PROVIDE GRANTS, FUNDS, AID AND ASSISTANCE TO SCIENTIFIC AND MEDICAL INSTITUTES, SCIENTISTS AND PHYSICIANS ENGAGED IN MEDICAL AND SCIENTIFIC RESEARCH AS TO THE CAUSES OF, PREVENTION OF, IEARLY DIAGNOSIS OF, AND TREATMENT OF CANCERS OF ALL TYPES; 2)TO PROMOTE AND SUPPORT THE USE OF CANCER-SPECIFIC PLATFORM TRIALS OF NEW DRUGS AND OTHER TREATMENTS OF CANCER SO THAT MULTIPLE TREATMENT MODALITIES MAY BE TESTED AND EVALUATED SIMULTANEOUSLY; ONGOING CLINICAL TRIALS MAY BE CONTINUOUSLY UPDATED TO INCORPORATE THE LATEST CLINICAL TRIAL RESEARCH RESULTS; AND THE MOST EFFECTIVE TREATMENT PROTOCOLS FOR VARIOUS TYPES OF CANCER MAY BE DEVELOPED AND APPROVED SOONER; 3)TO PROMOTE AND SUPPORT FINANCIALLY AND OTHERWISE, PUBLIC EDUCATION AS TO THE USE OF CANCER-SPECIFIC PLATFORM TRIALS THAT RESULT IN PROTOCOLS THAT MAY LEAD TO EARLIER DIAGNOSIS AND TREATMENT OF CANCERS OF ALL TYPES; 4)TO UNDERWRITE, SPONSOR, AND SUPPORT ACADEMIC AND SCHOLARLY STUDIES, SYMPOSIA, CURRICULA DEVELOPMENT, RESEARCH, SEMINA
IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt0N/A
IRS990EZ/ProhibitedTaxShelterTransInd0false
IRS990EZ/RelatedOrganizationCtrlEntInd0false
IRS990EZ/ScheduleBNotRequiredInd0X
IRS990EZ/SchoolOperatingInd0false
IRS990EZ/SubjectToProxyTaxInd0false
IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt0300000
IRS990EZ/TanningServicesProvidedInd0false
IRS990EZ/TotalExpensesAmt0105881
IRS990EZ/TransactionWithControlEntInd0false
IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990EZ/TypeOfOrganizationCorpInd0X
IRS990EZ/WebsiteAddressTxt0N/A
IRS990ScheduleA/First5Years509Ind0X
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt01
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt01
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportTotal509Amt01
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt01
IRS990ScheduleA/Total509Grp/TotalAmt01
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt01
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt01
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt0150000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BusinessName/BusinessNameLine1Txt0NOTE PAYABLE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BusinessName/BusinessNameLine2Txt0WINDMILL REALTY ADVISORS INC
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0WORKING CAPITAL
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt0150000
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/RelationshipWithOrgTxt0RELATED TO DIRECTOR
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0true
IRS990ScheduleL/TotalBalanceDueAmt0150000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0EXPENSES ADVERTISING AND PROMOTION 15,453 OFFICE 3,393 TRAVEL 4,989 INSURANCE 3,477 TOTAL 27,312
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1UNSECURED NOTES AND LOANS PAYABLE 0 150,000 LOANS FROM OFFICERS 0 150,000
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt21)TO PROVIDE GRANTS, FUNDS, AID AND ASSISTANCE TO SCIENTIFIC AND MEDICAL INSTITUTES, SCIENTISTS AND PHYSICIANS ENGAGED IN MEDICAL AND SCIENTIFIC RESEARCH AS TO THE CAUSES OF, PREVENTION OF, IEARLY DIAGNOSIS OF, AND TREATMENT OF CANCERS OF ALL TYPES; 2)TO PROMOTE AND SUPPORT THE USE OF CANCER-SPECIFIC PLATFORM TRIALS OF NEW DRUGS AND OTHER TREATMENTS OF CANCER SO THAT MULTIPLE TREATMENT MODALITIES MAY BE TESTED AND EVALUATED SIMULTANEOUSLY; ONGOING CLINICAL TRIALS MAY BE CONTINUOUSLY UPDATED TO INCORPORATE THE LATEST CLINICAL TRIAL RESEARCH RESULTS; AND THE MOST EFFECTIVE TREATMENT PROTOCOLS FOR VARIOUS TYPES OF CANCER MAY BE DEVELOPED AND APPROVED SOONER; 3)TO PROMOTE AND SUPPORT FINANCIALLY AND OTHERWISE, PUBLIC EDUCATION AS TO THE USE OF CANCER-SPECIFIC PLATFORM TRIALS THAT RESULT IN PROTOCOLS THAT MAY LEAD TO EARLIER DIAGNOSIS AND TREATMENT OF CANCERS OF ALL TYPES; 4)TO UNDERWRITE, SPONSOR, AND SUPPORT ACADEMIC AND SCHOLARLY STUDIES, SYMPOSIA, CURRICULA DEVELOPMENT, RESEARCH, SEMINARS, AND PRESENTATIONS AS TO THE TOPICS SET FORTH ABOVE IN GOVERNMENTAL INSTITUTIONS, IN THE MEDIA AND IN SCHOOLS, COLLEGES, UNIVERSITIES AND OTHER EDUCATIONAL INSTITUTIONS THROUGHOUT THE UNITED STATES AND ABROAD; 5)TO ENCOURAGE STATE AND FEDERAL GOVERNMENT AGENCIES TO PROVIDE ADEQUATE FUNDING TO PROMOTE THE USE OF CANCER-SPECIFIC PLATFORM TRIALS THAT CAN LEAD TO MORE EFFICACIOUS TREATMENTS OF CANCER AND THE ABILITY OF CANCER PATIENTS TO AVAIL THEMSELVES OF SUCH TREATMENTS SOONER THAN PREVIOUSLY POSSIBLE VIA STANDARD CLINICAL TRIAL PROTOCOLS. 6)TO ACCOMPLISH THE ABOVE PURPOSES BY ALL REASONABLE AND PRACTICAL MEANS, INCLUDING THE PUBLICATION AND DISSEMINATION OF INFORMATION IN ALL FORMS AND THROUGH ALL MEDIA, TO THE PUBLIC IN THE UNITED STATES AND IN FOREIGN STATES; AND 7)TO ENGAGE IN ANY LAWFUL ACTS AND ENTER INTO ALL LAWFUL AGREEMENTS THAT MAY BE NECESSARY, USEFUL, SUITABLE OR PROPER TO ACCOMPLISH THE CHARITABLE PURPOSES OF THE CORPORATION, PROVIDED THE SAME IS PERMITTED UNDER SECTION 501(C)(3) OF THE CODE.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3THE ORGANIZATION AMENDED ITS ARTICLES OF INCORPORATION TO CHANGE ITS NAME. A COPY OF THE ARTICLES OF AMENNDMENT WAS PREVIOUSLY SUBMITTED TO THE IRS ON DECEMBER 22, 2017.
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990-EZ, PART I, LINE 16
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990-EZ, PART II, LINE 26
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990-EZ, PART III
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990-EZ, PART V, LINE 34
ReturnHeader/BuildTS02018-06-14 16:35:46Z
ReturnHeader/BusinessOfficerGrp/PersonNm0BRIAN M ALEXANDER
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum06172996471
ReturnHeader/BusinessOfficerGrp/SignatureDt02018-05-15
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0GLOBAL COALITION FOR ADAPTIVE
ReturnHeader/Filer/BusinessName/BusinessNameLine2Txt0RESEARCH INC
ReturnHeader/Filer/BusinessNameControlTxt0GLOB
ReturnHeader/Filer/EIN0821199380
ReturnHeader/Filer/PhoneNum06172996471
ReturnHeader/Filer/USAddress/AddressLine1Txt01661 MASSACHUSETTS AVENUE BOX 427
ReturnHeader/Filer/USAddress/CityNm0LEXINGTON
ReturnHeader/Filer/USAddress/StateAbbreviationCd0MA
ReturnHeader/Filer/USAddress/ZIPCd0024209998
ReturnHeader/FilingSecurityInformation/AtSubmissionCreationDeviceId0502207283B69E2554CFB007E8895A735A19BDCEA
ReturnHeader/FilingSecurityInformation/AtSubmissionFilingDeviceId0502207283B69E2554CFB007E8895A735A19BDCEA
ReturnHeader/FilingSecurityInformation/FilingLicenseTypeCd0P
ReturnHeader/FilingSecurityInformation/IPAddress/IPv4AddressTxt065.200.43.29
ReturnHeader/FilingSecurityInformation/IPDt02018-05-15
ReturnHeader/FilingSecurityInformation/IPTimezoneCd0CD
ReturnHeader/FilingSecurityInformation/IPTm019:31:05
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0274279115
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0BARLOW DOUGLAS & HALL CPAS PLLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt01671 W HORIZON RIDGE PKWY STE 220
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0HENDERSON
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0NV
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0890123523
ReturnHeader/PreparerPersonGrp/PhoneNum07022022255
ReturnHeader/PreparerPersonGrp/PreparationDt02018-05-15
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0DEAN L WALKER CPA
ReturnHeader/ReturnTs02018-05-15T20:31:05-04:00
ReturnHeader/ReturnTypeCd0990EZ
ReturnHeader/TaxPeriodBeginDt02017-01-01
ReturnHeader/TaxPeriodEndDt02017-12-31
ReturnHeader/TaxYr02017

Document Assets

No mirrored PDF or thumbnail assets are attached yet.

Filings